MedTrace Logo

ACURATE Enhance Post Market Study

NCT06959862 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-06-24

No results posted yet for this study

Summary

The objective of the ACURATE Enhance study is to assess valve frame expansion and hemodynamics in a routine clinical setting when optimized procedural steps for valve implantation are followed.

Conditions

  • Aortic Valve Stenosis
  • Aortic Valve Calcification
  • Aortic Diseases

Interventions

DEVICE

Transcatheter Aortic Valve Implantation/Replacement

The device is placed in patients heart at the level of aortic valve through a transfemoral access from femoral groin as indicated in device IFU

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Andreas Rück · Karolinska Universitetssjukhuset, Enheten för kardiologi

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-12-31
Completion
2027-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06959862 on ClinicalTrials.gov